GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS cut its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.3% during the 4th quarter, Holdings Channel reports. The firm owned 97,145 shares of the company’s stock after selling 2,266 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in GE HealthCare Technologies were worth $7,595,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $31,000. Continuum Advisory LLC increased its position in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the period. Bank of Jackson Hole Trust acquired a new position in shares of GE HealthCare Technologies during the 4th quarter valued at $32,000. Flagship Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth $34,000. Finally, OFI Invest Asset Management acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth $34,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Price Performance

GEHC opened at $81.49 on Friday. The stock has a market cap of $37.27 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock has a fifty day moving average price of $87.02 and a 200 day moving average price of $86.02.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.